Market Value1,025,233,000
Total Holdings70
File Date2014-08-22
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Note this is an amended filing that contain additional holdings that were omitted from a previous filing. This is not likely to be an accurate picture of the total holdings of this firm.

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
US00163U1060 / AMAG Pharmaceuticals, Inc.
AEGR / Aegerion Pharmaceuticals, Inc.
AGEN / Agenus Inc.
032420101 / Anacor Pharmaceuticals, Inc.
ANGO / AngioDynamics, Inc.
ATRS / Antares Pharma Inc
ANTH / Anthera Pharmaceuticals, Inc.
NLTX / Neoleukin Therapeutics, Inc.
PETX / Aratana Therapeutics, Inc.
ATRC / AtriCure, Inc.
AUXL / Auxilium Pharmaceuticals Inc
BDSI / Biodelivery Sciences International
ALBO / Albireo Pharma Inc
VXRT / Vaxart, Inc.
BIOS / BioPlus Acquisition Corp - Class A
BKD / Brookdale Senior Living Inc.
CASM / CAS Medical Systems, Inc.
DXTR / Dextera Surgical Inc.
CFN / CareFusion Corporation
CPRX / Catalyst Pharmaceuticals, Inc.
CLTX / Celsus Therapeutics
MLNT / Melinta Therapeutics, Inc.
CCXI / ChemoCentryx Inc
CORI / Corium International, Inc.
DSCI / Derma Sciences, Inc.
ASRT / Assertio Holdings, Inc.
US2538277037 / Digirad Corp.
PLXP / PLx Pharma Inc.
WINT / Windtree Therapeutics, Inc.
DRRX / DURECT Corporation
DVAX / Dynavax Technologies Corporation
SESN / Sesen Bio Inc.
EBS / Emergent BioSolutions Inc.
AVDL / Avadel Pharmaceuticals plc
FLXN / Horizon Funds - Horizon Flexible Income ETF
HAE / Haemonetics Corporation
MRTX / Mirati Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
449575AB5 / Igi Laboratories Inc Bond
IDRA / Idera Pharmaceuticals, Inc.
451731103 / Ignyta, Inc.
IPXL / Impax Laboratories, Inc.
INFI / Infinity Pharmaceuticals Inc.
INFI / Infinity Pharmaceuticals Inc. Call
LJPC / La Jolla Pharmaceutical Co.
LBMH / Liberator Medical Holdings, Inc.
LPCN / Lipocine Inc.
NTUS / Natus Medical Inc
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
TENX / Tenax Therapeutics, Inc.
PTX / Pernix Therapeutics Holdings, Inc.
POZN / Pozen, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
NVLN / NOVELION THERAPEUTICS INC.
PHIO / Phio Pharmaceuticals Corp.
REPH / Societal CDMO Inc
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
RAD / Rite Aid Corp.
SGNT / Sagent Pharmaceuticals, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Put
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
TNXP / Tonix Pharmaceuticals Holding Corp.
TRVN / Trevena, Inc.
UAM / Universal American Corp.
XNCR / Xencor, Inc.
ZGNX / Zogenix Inc
ELOS / Syneron Medical Ltd.